The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The year in cardiovascular medicine 2023: the top 10 papers in thrombosis and antithrombotic treatment

Published:2024-03-15 Issue:19 Volume:45 Page:1727-1729
ISSN:0195-668X
Container-title:European Heart Journal
language:en
Short-container-title:

Author:

Andreotti Felicita¹²^ORCID,O’Donoghue Michelle L³,Ten Berg Jurriën M⁴⁵

Affiliation:

1. Department of Cardiovascular Science, Fondazione Policlinico Universitario A. Gemelli IRCCS , Largo A. Gemelli 8, 00168 Rome , Italy

2. Catholic University Medical School , Cardio-Respiratory Department, Largo F. Vito 1, 00168 Rome , Italy

3. TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital , Boston, MA , USA

4. Department of Cardiology, St. Antonius Hospital , Nieuwegein , the Netherlands

5. Department of Cardiology, University Medical Center Maastricht , Maastricht , the Netherlands

Publisher

Oxford University Press (OUP)

Link

https://academic.oup.com/eurheartj/article-pdf/45/19/1727/58720973/ehae123.pdf

Reference15 articles.

1. Comprehensive meta-analysis of safety and efficacy of bivalirudin versus heparin with or without routine glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndrome;Navarese;JACC Cardiovasc Interv,2015

2. Bivalirudin plus a high-dose infusion versus heparin monotherapy in patients with ST segment elevation myocardial infarction undergoing primary percutaneous coronary intervention: a randomised trial;Li;Lancet,2022

3. Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials;Galli;Eur Heart J,2022

4. Time for a paradigm shift? Making the case for tailored selection of antiplatelet therapy;O'Donoghue;Eur Heart J,2022

5. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trials;Costa;Eur Heart J,2023

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation for transient atrial fibrillation post-coronary bypass: high quality evidence needed;European Heart Journal;2024-07-16

2. Environmental factors in the development of Coronary Artery Atherosclerosis;2024-07-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3